Casdin Capital backs Boston startup 908 Devices

Boston-based 908 Devices, a provider of analytical devices for chemical analysis, has secured additional financing, raising its overall funding tally to $29 million. The investors included Casdin Capital and Dr. Martin Madaus, chairman and CEO of Ortho Clinical Diagnostics.

1 July 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail